BIIB vs CLOV · P/E 21, rev $9.89B vs rev $1.37B
Biogen Inc (BIIB) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BIIB and CLOV stock pages for the full models.
Not investment advice.